93319-46-1

Basic information

• Product Name: 1,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
• Synonyms: 1H-pyrazolo[3,4-d]pyrimidin-4-amine, 1,6-diphenyl-
• CAS NO: 93319-46-1
• Molecular Formula: C₁₇H₁₃N₅
• Molecular Weight: 287.3186
• Mol File: 93319-46-1.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 396.4°C at 760 mmHg
• Flash Point: 193.5°C
• Density: 1.34g/cm³
• Vapor Pressure: 1.72E-06mmHg at 25°C
• Refractive Index: 1.733
• CAS DataBase Reference: 1,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine(93319-46-1)
• EPA Substance Registry System: 1,6-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine(93319-46-1)

Safety Data

• Hazardous Substances Data: 93319-46-1(Hazardous Substances Data)

Usage

Type of compound

Heterocyclic organic compound

Core structure

Pyrazolo-pyrimidin-4-amine

Potential applications

Pharmaceutical research

Development

New drugs and therapeutic agents

Other possible uses

Material science, chemical intermediate in organic synthesis

Specific properties and uses

Depend on further research and testing

Upstream product

• 5334-43-0 5-Amino-4-cyano-1-phenylpyrazole 
• 100-47-0 benzonitrile 
• 82216-47-5 2-Phenyl-4-(5-phenyl-[1,2,4]oxadiazol-3-yl)-2H-pyrazol-3-ylamine 
• 94079-00-2 5-Amino-N-benzoyl-1-phenyl-4-pyrazolcarboxamidin 

Relevant articles and documents

PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF

This invention relates with the arylheterocycle-fused pyrimidines, derivatives and analogs of formula I: or stereoisomers, tautoers, prodrugs, pharmaceutically acceptable salts, complex salts or solvates thereof, wherein: A-cycle is of 3-8 saturated or unsaturated arylheterocycles or aliheterocyclic, containing 1-4 heteroatoms, B-cycle 5-8 member saturated or unsaturated heterocycle containing 1-4 heteroatoms; X1, X2, X3, X4 are, independently at each occurrence, C, O, S, Se, N and P elements; R1, R2, R3 is a substituent containing alicyclic group, arylcycle group, heterocyclic group, adamantane alkyl, adamantane heterocycle, adamantane analogs, sugar group, hydroxyl group, amino acid group or a combination of the above substituents. This invention also relates with their preparative methods and applications.